| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |